Company Filing History:
1 out of 16 
1 out of 134 
Years Active: 2014
Title: Arnaud Gilles: Innovator in Viral Infection Treatment
Introduction
Arnaud Gilles is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of viral infections. His innovative work has led to the development of compounds that enhance therapeutic potency against various viral pathogens.
Latest Patents
Gilles holds a patent for "Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections." This patent focuses on phosphoramidate compounds derived from guanine bases, which exhibit enhanced potency in treating viral infections, such as the hepatitis C virus. The patent also includes pharmaceutical compositions, methods for preparing these compounds, and their applications in treating viral infections.
Career Highlights
Throughout his career, Arnaud Gilles has worked with prominent organizations, including Inhibitex, Inc. and University College Cardiff Consultants Limited. His experience in these institutions has allowed him to advance his research and contribute to the development of effective antiviral therapies.
Collaborations
Gilles has collaborated with notable professionals in his field, including Stanley Dawes Chamberlain and Jeff T Hutchins. These collaborations have further enriched his research and innovation efforts.
Conclusion
Arnaud Gilles is a distinguished inventor whose work in developing phosphoramidate derivatives has the potential to significantly impact the treatment of viral infections. His contributions to pharmaceutical sciences highlight the importance of innovation in addressing global health challenges.